glp 1 agonists with cardiovascular benefit Frontiers Comprehensive Overview of GLP-1 RAs

26 Certain GLP-1 agonist drugs have been associated with a significantly increased risk of depression and anxiety, 27 highlighting an emerging need for complimentary therapies to support patients mental and emotional health while undergoing pharmaceutical GLP-1 therapy

Laekna showcased LAE102 (ActRIIA antibody) for muscle regeneration and fat loss

These may include: Nausea, vomiting or diarrhoea (most common early on) Constipation Fatigue Mild increases in heart rate (similar to changes seen with GLP-1 medicines) Side effects were more frequent at higher doses (8 mg and 12 mg), but still rated mild to moderate overall

Step 3: Activate your device to start tracking your progress

He W, Kapate N, Shields CWT, Mitragotri S

30 In the LEAD 6 trial, following the main 26week, randomised, doubleblind phase, 187 patients who had been receiving exenatide twice daily 10 g were switched to liraglutide 1.8 mg